Rare Cancers: Clinical Trials and Research
The question
To ask the Secretary of State for Health and Social Care, whether he plans to ensure patients can (a) get better access to and (b) find out about (i) research and (ii) clinical trials for rare cancers.
Answered by Ashley Dalton
The Department is committed to maximising our potential to lead the world in clinical trials and ensuring that clinical trials are more accessible.
The Department funded National Institute for Health and Care Research (NIHR) funds research and research infrastructure, which supports patients and the public to participate in high-quality research, including clinical research on rare cancers. NIHR research expenditure for all cancers was £133 million in 2023/24, reflecting its high priority. These investments are pivotal to informing efforts to improve cancer prevention, treatment, and outcomes, including for rare cancers.
The NIHR provides an online service called Be Part of Research, which promotes participation in health and social care research, including research into rare cancers, by allowing users to search for relevant studies and register their interest. This makes it easier for people to find and take part in health and care research that is relevant to them.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →